DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Fenaux P, Mufti GJ, Hellstrom-Lindberg E et al.
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Lancet Oncol 2009;
10: 223-232
We do not assume any responsibility for the contents of the web pages of other providers.